These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1578485)

  • 1. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biochemical properties of 6-bromoandrostenedione derivatives with a 2,2-dimethyl or 2-methyl group as aromatase inhibitors.
    Numazawa M; Handa W; Yamada K
    Biol Pharm Bull; 2004 Nov; 27(11):1878-82. PubMed ID: 15516742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M; Yoshimura A; Tachibana M; Shelangouski M; Ishikawa M
    Steroids; 2002 Mar; 67(3-4):185-93. PubMed ID: 11856542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
    Numazawa M; Mutsumi A; Tsuji M
    Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological characterization of A-ring steroids.
    Johnston JO; Wright CL; Burkhart JP; Peet NP
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
    Osawa Y; Osawa Y; Coon MJ
    Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
    O'Reilly JM; Li N; Duax WL; Brueggemeier RW
    J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
    Numazawa M; Shelangouski M; Nagasaka M
    Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
    Abul-Hajj YJ; Liu XP; Hedge M
    Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.